Finance

Lists
Q3 2026 earnings • released • EPS beat +19.86% • Revenue beat +2.39%
See results
NCLH:NYSE
Norwegian Cruise Line Holdings Ltd
$17.57
-3.49%
(-0.64) 1D
$17.58
+0.06% (+0.010)
After hours
Closed: Oct 30, 3:00:09 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NCLH...
Open
$17.91
High
$17.98
Low
$17.31
Mkt. cap
8.07B
Avg. vol.
22.17M
Volume
28.32M
P/E ratio
11.11
52-wk high
$25.12
52-wk low
$13.63
EPS
$1.58
Beta
1.95
Shares outstanding
459.19M
No. of employees
44K
Open
$17.91
High
$17.98
Low
$17.31
Mkt. cap
8.07B
Avg. vol.
22.17M
Volume
28.32M
P/E ratio
11.11
52-wk high
$25.12
52-wk low
$13.63
EPS
$1.58
Beta
1.95
Shares outstanding
459.19M
No. of employees
44K
News stories
From web sources and news partners
Profile
Norwegian Cruise Line Holdings Ltd. is a holding company that is based in the United States and domiciled in Bermuda. It operates three cruise lines as wholly owned subsidiaries: Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. With its subsidiaries combined, it is the third-largest cruise operator in the world. It is a publicly traded company listed on the New York Stock Exchange. Wikipedia
About Norwegian Cruise Line Holdings Ltd
CEO-
Employees44.5K
FoundedFeb 21, 2011
HeadquartersMiami, Florida, United States
SectorResort
Websitenclhltd.com
Analyst ratings
Based on 19 analysts giving stock ratings to NCLH in the past 3 months
Hold
Buy
5
Hold
13
Sell
1
12-month forecast
Based on 19 Wall Street analysts offering 12 month price targets for NCLH in the last 3 months.
Highest
Current $17.57
$24.00 (+36.60%)
Average
$18.59 (+5.81%)
Lowest
$13.00 (-26.01%)
Analyst
Recommendation
Action
Price target
Projected
Date
Manucher Narzulloev
Freedom Capital Markets
Buy
Upgraded
$22.00
+25.2%
10/30/2026
Lizzie Dove
Goldman Sachs
Hold
Maintained
$16.00
-8.9%
10/30/2026
Robin M. Farley
UBS
Hold
Maintained
$20.00
+13.8%
10/29/2026
James Hardiman
Citi
Buy
Maintained
$21.00
+19.5%
10/30/2026
Steven Wieczynski
Stifel Nicolaus
Buy
Maintained
$24.00
+36.6%
10/30/2026
Benjamin Chaiken
Mizuho Securities
Hold
Maintained
$18.00
+2.4%
10/30/2026
Brandt Montour
Barclays
Hold
Maintained
$18.00
+2.4%
10/29/2026
Trey Bowers
Wells Fargo
Buy
Maintained
$22.00
+25.2%
10/29/2026
Matthew Boss
J.P. Morgan
Sell
Maintained
$13.00
-26%
10/29/2026
Stephen Grambling
Morgan Stanley
Hold
Maintained
$19.00
+8.1%
10/22/2026
Thomas Fitzgerald CFA
TD Cowen
Buy
Maintained
$20.00
+13.8%
10/20/2026
Christopher Stathoulopoulos
Susquehanna
Hold
Maintained
$16.00
-8.9%
10/20/2026
Tristan M. Thomas-Martin
BMO Capital
Hold
Reiterated
$21.00
+19.5%
10/13/2026
Richard Clarke
Bernstein
Hold
Maintained
$16.00
-8.9%
10/13/2026
Andrew Didora
Bank of America Securities
Hold
Maintained
$17.00
-3.2%
10/13/2026
David Katz
Jefferies
Hold
Reiterated
$17.00
-3.2%
10/08/2026
Chris Woronka
Deutsche Bank
Hold
Maintained
-
-
09/28/2026
Patrick Scholes
Truist Financial
Hold
Maintained
$16.00
-8.9%
09/24/2026
John Staszak
Argus Research
Hold
Maintained
-
-
08/19/2026
Kevin Kopelman
TD Cowen
Buy
Maintained
$24.00
+36.6%
07/30/2026
Unknown Analyst
Freedom Capital Markets
Buy
Initiated
$24.00
+36.6%
06/03/2026
Brandon Rolle
Loop Capital Markets
Buy
Initiated
$22.00
+25.2%
06/01/2026
Andrew May
Northcoast Research
Hold
Downgraded
-
-
05/06/2026
Unknown Analyst
Argus Research
Hold
Reiterated
-
-
05/06/2026
Ivan Feinseth
Tigress Financial
Buy
Reiterated
$32.00
+82.1%
04/17/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
$1.12 / $0.93
+19.86%beat
Revenue / Est. (USD)
2.95B / 2.88B
+2.39%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.94B
2.24B
2.33B
2.64B
Cost of goods sold
1.55B
1.32B
1.38B
1.59B
Cost of revenue
1.55B
1.32B
1.38B
1.59B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
383.00M
381.39M
447.51M
411.74M
Operating expense
633.83M
734.26M
708.22M
682.95M
Total operating expenses
2.19B
2.06B
2.09B
2.27B
Operating income
749.45M
186.63M
245.12M
370.79M
Other non operating income
6.20M
-4.60M
1.95M
-2.58M
EBT including unusual items
433.64M
5.89M
107.66M
225.96M
EBT excluding unusual items
588.12M
5.89M
119.88M
233.42M
Income tax expense
14.34M
-8.36M
2.99M
3.40M
Effective tax rate
3.31%
-141.96%
2.78%
1.51%
Other operating expenses
-
-
-
-
Net income
419.30M
14.25M
104.67M
222.55M
Net profit margin
14.27%
0.64%
4.49%
8.43%
Earnings per share
1.20
0.28
0.23
0.48
Interest and investment income
-
-
-
-
Interest expense
-174.33M
-170.04M
-165.99M
-170.89M
Net interest expenses
-174.33M
-170.04M
-165.99M
-170.89M
Depreciation and amortization charges
250.83M
352.87M
260.72M
271.20M
EBITDA
1.00B
446.14M
505.83M
641.99M
Gain or loss from assets sale
-2.03M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps